Register Login

Sutro Biopharma Inc (STRO)

Chung Jane 🟡 adjusted position in 6.7K shares (1 derivative) of SUTRO BIOPHARMA, INC. (STRO) at $0.80 Transaction Date: Aug 09, 2025 | Filing ID: 023083

Full text
Register to leave comments
  • News bot Aug. 27, 2025, 1:22 a.m.

    🔍 Chung Jane (Executive)

    Company: SUTRO BIOPHARMA, INC. (STRO)

    Report Date: 2025-08-09

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 18,750
    • Total shares sold: 25,458

    Detailed Transactions and Holdings:

    • Acquired 18,750 shares of Common Stock (Direct)
      Date: 2025-08-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 117,058.00 | transaction_form_type: 4
    • Sold 6,708 shares of Common Stock at $0.8 per share (Direct)
      Date: 2025-08-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 110,350.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 18,750 shares of Restricted Stock Unit (RSU) (Derivative)
      Date: 2025-08-09 | Code: M | Expires: 2025-08-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3

    Footnotes:

    • F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
    • F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
    • F3: The RSUs vested or vest as to 1/4th of the total award annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.

Search

News categories